Lei Lv

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Signaling Pathway

Epithelial Mesenchymal Transition

Top Venues

Cell death discovery

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Qiyi Yi, Yujia Zhao, Ran Xia, Qinqin Wei, Fengmei Chao, Rui Zhang, Po Bian, Lei Lv
TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750. Cell death discovery 9 (1) (2023)
Lu Li, Lei Lv, Jun-Chao Xu, Qing He, Na Chang, Ya-Yun Cui, Zhen-Chao Tao, Tao Zhu, Li-Ting Qian
RIG-I Promotes Tumorigenesis and Confers Radioresistance of Esophageal Squamous Cell Carcinoma by Regulating DUSP6. International journal of molecular sciences 24 (6) (2023)
Lu Li, Lei Lv, Jun-Chao Xu, Qing He, Na Chang, Ya-Yun Cui, Zhen-Chao Tao, Tao Zhu, Li-Ting Qian
RIG-I Promotes Tumorigenesis and Confers Radioresistance of Esophageal Squamous Cell Carcinoma by Regulating DUSP6. International journal of molecular sciences 24 (6) (2023)
Lu Li, Lei Lv, Jun-Chao Xu, Qing He, Na Chang, Ya-Yun Cui, Zhen-Chao Tao, Tao Zhu, Li-Ting Qian
RIG-I Promotes Tumorigenesis and Confers Radioresistance of Esophageal Squamous Cell Carcinoma by Regulating DUSP6. International journal of molecular sciences 24 (6) (2023)
Qiyi Yi, Yujia Zhao, Ran Xia, Qinqin Wei, Fengmei Chao, Rui Zhang, Po Bian, Lei Lv
TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750. Cell death discovery 9 (1) (2023)
Qiyi Yi, Youguang Pu, Fengmei Chao, Po Bian, Lei Lv
ACAP1 Deficiency Predicts Inferior Immunotherapy Response in Solid Tumors. Cancers 14 (23) (2022)
Qiyi Yi, Youguang Pu, Fengmei Chao, Po Bian, Lei Lv
ACAP1 Deficiency Predicts Inferior Immunotherapy Response in Solid Tumors. Cancers 14 (23) (2022)
Qiyi Yi, Youguang Pu, Fengmei Chao, Po Bian, Lei Lv
ACAP1 Deficiency Predicts Inferior Immunotherapy Response in Solid Tumors. Cancers 14 (23) (2022)
Tian Tian, Fu Hong, Zhiwen Wang, Jiaru Hu, Ni Chen, Lei Lv, Qiyi Yi
HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma. Cell death discovery 7 (1) (2021)